D Pieniazek

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast
    D Pieniazek
    Division of AIDS, STD, and TB Laboratory Research, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 15:603-8. 1999
  2. pmc Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon
    D Pieniazek
    HIV Retrovirus Diseases Branch, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 4:649-56. 1998
  3. ncbi request reprint Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G
    D L Ellenberger
    HIV and Retrovirology Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 15:3-9. 1999
  4. pmc Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection
    J Dorn
    HIV Immunology and Diagnostics Branch, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevntion, Atlanta, Georgia 30333, USA
    J Clin Microbiol 38:773-80. 2000
  5. ncbi request reprint Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States
    P J Weidle
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 181:470-5. 2000
  6. ncbi request reprint Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model
    R A Otten
    HIV AIDS and Retrovirology Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 180:673-84. 1999
  7. pmc Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil
    A Ramos
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 5:65-74. 1999
  8. pmc Predominance of HIV-1 subtype A and D infections in Uganda
    D J Hu
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 6:609-15. 2000
  9. pmc Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping
    S M Agwale
    Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Clin Microbiol 39:2110-4. 2001
  10. ncbi request reprint Resistance to antiretroviral therapy among patients in Uganda
    P J Weidle
    Division of HIV AIDS Prevention, National Center for HIV, Sexually Transmitted Diseases, and Tuberculosis Prevention, U S Centers for Disease Control and Prevention CDC, Atlanta, Georgia 30333, USA
    J Acquir Immune Defic Syndr 26:495-500. 2001

Collaborators

  • D J Hu
  • R B Lal
  • S Z Wiktor
  • M Janini
  • G M Matar
  • K E Robbins
  • J P McGowan
  • K Hertogs
  • K L Irwin
  • R G Downing
  • F Gao
  • P J Weidle
  • A Ramos
  • M A Rayfield
  • D L Ellenberger
  • S M Agwale
  • J Dorn
  • J Nkengasong
  • R A Otten
  • R Respess
  • M L Kalish
  • O M Njoku
  • P Dehertogh
  • A Edubio
  • D Hone
  • C Zeh
  • E Lackritz
  • S Bloor
  • B Larder
  • P Mugyenyi
  • C Wambebe
  • C M Kityo
  • A Saekhou
  • M F Gboun
  • M Reitz
  • N Sani-Gwarzo
  • A Kebba
  • T M Folks
  • V De Vroey
  • L Odama
  • C Schable
  • C Yang
  • S Masciotra
  • C E Ganea
  • N Olivo
  • T D Mastro
  • B Biryahwaho
  • S D Holmberg
  • J A Ernst
  • M Schechter
  • E Jackson
  • C C Luo
  • D R Adams
  • C I Bandea
  • C Fridlund
  • I M Coulibaly
  • G Schochetman
  • J Baggs
  • A Tanuri
  • E Ekpini
  • S Devare
  • C Maurice
  • C A Fridlund
  • A E Greenberg
  • M C Cabral

Detail Information

Publications10

  1. ncbi request reprint Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast
    D Pieniazek
    Division of AIDS, STD, and TB Laboratory Research, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 15:603-8. 1999
    ..Our data indicate that viruses of subtypes A and B have contributed to the HIV-2 epidemic in Ivory Coast...
  2. pmc Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon
    D Pieniazek
    HIV Retrovirus Diseases Branch, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 4:649-56. 1998
    ..Blood screening for both HIV-1 and HIV-2 in Lebanon is recommended to protect the blood supply. HIV subtype data provide information for vaccine development...
  3. ncbi request reprint Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G
    D L Ellenberger
    HIV and Retrovirology Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 15:3-9. 1999
    ..This study demonstrates that clade A is the predominant HIV-1 subtype in HIV-seropositive individuals in Abidjan, Ivory Coast and that these strains are phylogenetically distinct from other subtype A strains observed in East Africa...
  4. pmc Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection
    J Dorn
    HIV Immunology and Diagnostics Branch, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevntion, Atlanta, Georgia 30333, USA
    J Clin Microbiol 38:773-80. 2000
    ....
  5. ncbi request reprint Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States
    P J Weidle
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, and Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 181:470-5. 2000
    ....
  6. ncbi request reprint Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model
    R A Otten
    HIV AIDS and Retrovirology Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 180:673-84. 1999
    ..These findings demonstrate a window period for susceptibility to dual infection and indicate that protection from retroviral infection may be achievable...
  7. pmc Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil
    A Ramos
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 5:65-74. 1999
    ....
  8. pmc Predominance of HIV-1 subtype A and D infections in Uganda
    D J Hu
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 6:609-15. 2000
    ....
  9. pmc Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping
    S M Agwale
    Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Clin Microbiol 39:2110-4. 2001
    ..7%) could be amplified with the standard C2V5 primers. Therefore, gp41-based HMA can be a useful tool for the rapid monitoring of prevalent subtypes in countries with divergent strains of circulating HIV-1...
  10. ncbi request reprint Resistance to antiretroviral therapy among patients in Uganda
    P J Weidle
    Division of HIV AIDS Prevention, National Center for HIV, Sexually Transmitted Diseases, and Tuberculosis Prevention, U S Centers for Disease Control and Prevention CDC, Atlanta, Georgia 30333, USA
    J Acquir Immune Defic Syndr 26:495-500. 2001
    ..To characterize HIV-1 phenotypic resistance patterns and genotypic mutations among patients taking antiretroviral medications in Uganda...